What if we could manufacture valuable medicines and other high-value molecules without relying on living cells?
In this Forbes feature, discover how eXoZymes is combining AI, engineered enzymes, and cell-free biomanufacturing to challenge traditional manufacturing methods - and turn breakthrough science into commercial opportunities.
🔗 Read the full Forbes feature here